Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 31.34%751.99M | 24.97%691.06M | 14.39%621.3M | 8.93%2.34B | 21.91%675.43M | 5.58%572.57M | 1.91%552.99M | 5.90%543.15M | 4.01%2.15B | 6.32%554.06M |
| Cost of revenue | 53.28%297.76M | 36.50%295.24M | 9.71%240.35M | -1.70%900.6M | 15.23%270.96M | -15.90%194.26M | -6.39%216.3M | 0.06%219.08M | 4.22%916.15M | 4.13%235.14M |
| Gross profit | 20.07%454.23M | 17.56%395.81M | 17.55%380.95M | 16.81%1.44B | 26.83%404.47M | 21.52%378.32M | 8.06%336.69M | 10.24%324.07M | 3.85%1.24B | 7.99%318.92M |
| Operating expense | 25.05%77.57M | 19.77%74.2M | 23.01%66.17M | 25.60%249.08M | 51.18%71.3M | 21.28%62.03M | 20.76%61.95M | 10.47%53.8M | -17.33%198.31M | -36.82%47.16M |
| Selling and administrative expenses | 45.91%10.81M | 12.92%9.14M | 18.80%8.39M | 10.80%31.53M | 34.04%8.97M | 15.61%7.41M | -20.71%8.09M | 37.09%7.06M | -39.82%28.45M | -72.15%6.69M |
| -General and administrative expense | 45.91%10.81M | 12.92%9.14M | 18.80%8.39M | 10.80%31.53M | 34.04%8.97M | 15.61%7.41M | -20.71%8.09M | 37.09%7.06M | -39.82%28.45M | -72.15%6.69M |
| Other operating expenses | 9.81%67.54M | 19.05%66.48M | 23.09%59.61M | 14.21%229.42M | 15.89%63.63M | 31.62%61.51M | 12.35%55.85M | -2.23%48.43M | 0.15%200.88M | 4.81%54.9M |
| Total other operating income | -88.75%774K | -28.40%1.42M | 7.77%1.83M | -61.75%11.87M | -90.99%1.3M | 246.13%6.88M | -76.93%1.99M | -71.65%1.7M | 289.00%31.02M | 722.98%14.44M |
| Operating profit | 19.09%376.66M | 17.06%321.61M | 16.46%314.77M | 15.13%1.19B | 22.60%333.17M | 21.57%316.28M | 5.56%274.73M | 10.20%270.28M | 9.20%1.04B | 23.15%271.76M |
| Net non-operating interest income (expenses) | -105.76%-27.17M | -145.80%-23.1M | -171.93%-23.13M | -42.41%-63M | -132.44%-24.69M | -27.59%-13.2M | 4.98%-9.4M | 21.78%-8.5M | 24.18%-44.24M | 15.58%-10.62M |
| Non-operating interest income | 4.88%5.63M | 70.35%5.19M | 62.40%6.17M | 25.45%10.52M | 68.08%5.51M | 109.80%5.37M | 32.62%3.05M | 37.72%3.8M | 34.88%8.39M | -8.95%3.28M |
| Non-operating interest expense | 76.59%32.8M | 127.32%28.29M | 138.10%29.3M | 39.71%73.53M | 117.26%30.2M | 43.90%18.57M | 2.11%12.45M | -9.73%12.31M | -18.49%52.63M | -14.11%13.9M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 187.32%7.21M | -58.53%2.51M | ||||||||
| Income from associates and other participating interests | -251.81%-882K | 264.90%2M | -77.58%820K | -100.18%-19K | -343.54%-4.81M | -77.16%581K | -84.32%547K | 46.97%3.66M | -77.26%10.5M | -95.43%1.97M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 14.80%348.61M | 13.02%300.51M | 10.19%292.47M | 13.16%1.14B | 15.42%303.68M | 20.33%303.66M | 4.73%265.88M | 12.05%265.43M | 6.60%1.01B | 4.71%263.11M |
| Income tax | 9.79%77.5M | 10.86%68.88M | 14.90%70M | 6.12%240.67M | -17.55%47.02M | 23.07%70.59M | 5.13%62.14M | 14.31%60.92M | -7.19%226.78M | 251.42%57.03M |
| Net income | 16.32%271.11M | 13.68%231.63M | 8.78%222.46M | 15.21%897.98M | 24.54%256.65M | 19.52%233.07M | 4.61%203.75M | 11.40%204.51M | 11.41%779.43M | -12.32%206.08M |
| Net income continuous operations | 16.32%271.11M | 13.68%231.63M | 8.78%222.46M | 15.21%897.98M | 24.54%256.65M | 19.52%233.07M | 4.61%203.75M | 11.40%204.51M | 11.41%779.43M | -12.32%206.08M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 16.32%271.11M | 13.68%231.63M | 8.78%222.46M | 15.21%897.98M | 24.54%256.65M | 19.52%233.07M | 4.61%203.75M | 11.40%204.51M | 11.41%779.43M | -12.32%206.08M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 16.32%271.11M | 13.68%231.63M | 8.78%222.46M | 15.21%897.98M | 24.54%256.65M | 19.52%233.07M | 4.61%203.75M | 11.40%204.51M | 11.41%779.43M | -12.32%206.08M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 15.96%0.0792 | 13.55%0.0679 | 8.67%0.0652 | 15.18%0.2633 | 24.67%0.0753 | 19.41%0.0683 | 4.73%0.0598 | 11.52%0.06 | 11.40%0.2286 | -12.34%0.0604 |
| Diluted earnings per share | 15.96%0.0792 | 13.55%0.0679 | 8.67%0.0652 | 15.18%0.2633 | 24.67%0.0753 | 19.41%0.0683 | 4.73%0.0598 | 11.52%0.06 | 11.40%0.2286 | -12.34%0.0604 |
| Dividend per share | 11.70%0.0993 | 0 | 24.54%0.1086 | 12.52%0.1761 | 0 | 8.55%0.0889 | 0 | 16.89%0.0872 | -3.34%0.1565 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.